Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (81-90 of 470) with videos related to

Pageof 47
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 16, 2024
Modifiable Risk Factors Associated With Cognitive Decline in Late Life Depression: Findings From the Canadian Longitudinal Study on Aging: Facteurs de risque modifiables associés au déclin cognitif dans la dépression en fin de vie : constatations de l'Étude longitudinale canadienne sur le vieillissementMelissa Wong, Alex Kiss, Nathan Herrmann, et al.
Dementia and Geriatric Cognitive Disorders|April 2, 2005
Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's diseaseDaphne M Geslani, Mary C Tierney, Nathan Herrmann, et al.
Journal of Psychiatric Research|September 17, 2018
The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysisAdam Dinoff, Nathan Herrmann, Walter Swardfager, et al.
Dementia and Geriatric Cognitive Disorders Extra|September 5, 2017
Assessing Capacity in the Elderly: Comparing the MoCA with a Novel Computerized Battery of Executive FunctionMegan Brenkel, Kenneth Shulman, Elias Hazan, et al.
Journal of the American Geriatrics Society|May 22, 2003
Contribution of informant and patient ratings to the accuracy of the mini-mental state examination in predicting probable Alzheimer's diseaseMary C Tierney, Nathan Herrmann, Daphne M Geslani, et al.
Neurochemistry International|December 5, 2021
Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospectsShankar Tumati, Nathan Herrmann, Giovanni Marotta, et al.
International Psychogeriatrics|July 4, 2015
Can clock drawing differentiate Alzheimer's disease from other dementias?Lynnette Pei Lin Tan, Nathan Herrmann, Brian J Mainland, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 30, 2006
Prevalence and correlates of agoraphobia in older adultsLaura McCabe, John Cairney, Scott Veldhuizen, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trialJennifer R Glass, Beth A Sproule, Nathan Herrmann, et al.
Clinical Therapeutics|October 17, 2002
How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experienceCarolyn S Dewa, Gary Remington, Nathan Herrmann, et al.
Pageof 47

Showing results (81-90 of 470) with videos related to

Sort By:
Pageof 47
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|May 16, 2024
Modifiable Risk Factors Associated With Cognitive Decline in Late Life Depression: Findings From the Canadian Longitudinal Study on Aging: Facteurs de risque modifiables associés au déclin cognitif dans la dépression en fin de vie : constatations de l'Étude longitudinale canadienne sur le vieillissementMelissa Wong, Alex Kiss, Nathan Herrmann, et al.
Dementia and Geriatric Cognitive Disorders|April 2, 2005
Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's diseaseDaphne M Geslani, Mary C Tierney, Nathan Herrmann, et al.
Journal of Psychiatric Research|September 17, 2018
The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysisAdam Dinoff, Nathan Herrmann, Walter Swardfager, et al.
Dementia and Geriatric Cognitive Disorders Extra|September 5, 2017
Assessing Capacity in the Elderly: Comparing the MoCA with a Novel Computerized Battery of Executive FunctionMegan Brenkel, Kenneth Shulman, Elias Hazan, et al.
Journal of the American Geriatrics Society|May 22, 2003
Contribution of informant and patient ratings to the accuracy of the mini-mental state examination in predicting probable Alzheimer's diseaseMary C Tierney, Nathan Herrmann, Daphne M Geslani, et al.
Neurochemistry International|December 5, 2021
Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospectsShankar Tumati, Nathan Herrmann, Giovanni Marotta, et al.
International Psychogeriatrics|July 4, 2015
Can clock drawing differentiate Alzheimer's disease from other dementias?Lynnette Pei Lin Tan, Nathan Herrmann, Brian J Mainland, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 30, 2006
Prevalence and correlates of agoraphobia in older adultsLaura McCabe, John Cairney, Scott Veldhuizen, et al.
Journal of Clinical Psychopharmacology|March 18, 2008
Effects of 2-week treatment with temazepam and diphenhydramine in elderly insomniacs: a randomized, placebo-controlled trialJennifer R Glass, Beth A Sproule, Nathan Herrmann, et al.
Clinical Therapeutics|October 17, 2002
How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experienceCarolyn S Dewa, Gary Remington, Nathan Herrmann, et al.
Pageof 47